Susquehanna International Group’s ChemoCentryx, Inc. CCXI Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2022
Q4 | – | Sell |
-219,200
| Closed | -$11.3M | – | 14594 |
|
|
2022
Q3 | $11.3M | Buy |
219,200
+43,300
| +25% | +$1.79M | ﹤0.01% | 1997 |
|
|
2022
Q2 | $4.36M | Sell |
175,900
-115,600
| -40% | -$2.55M | ﹤0.01% | 3410 |
|
|
2022
Q1 | $7.31M | Sell |
291,500
-51,900
| -15% | -$1.46M | ﹤0.01% | 3010 |
|
|
2021
Q4 | $12.5M | Sell |
343,400
-136,700
| -28% | -$4.8M | ﹤0.01% | 2421 |
|
|
2021
Q3 | $8.21M | Buy |
480,100
+132,900
| +38% | +$2.07M | ﹤0.01% | 3162 |
|
|
2021
Q2 | $4.65M | Buy |
347,200
+328,700
| +1,777% | +$8.1M | ﹤0.01% | 4166 |
|
|
2021
Q1 | $948K | Sell |
18,500
-178,300
| -91% | -$10.7M | ﹤0.01% | 7879 |
|
|
2020
Q4 | $12.2M | Sell |
196,800
-92,600
| -32% | -$5.3M | ﹤0.01% | 2270 |
|
|
2020
Q3 | $15.9M | Buy |
289,400
+138,900
| +92% | +$7.48M | ﹤0.01% | 1712 |
|
|
2020
Q2 | $8.66M | Sell |
150,500
-67,000
| -31% | -$3.65M | ﹤0.01% | 2309 |
|
|
2020
Q1 | $8.74M | Sell |
217,500
-29,700
| -12% | -$1.26M | ﹤0.01% | 1884 |
|
|
2019
Q4 | $9.78M | Buy |
247,200
+159,200
| +181% | +$2.8M | ﹤0.01% | 2106 |
|
|
2019
Q3 | $597K | Buy |
88,000
+17,400
| +25% | +$131K | ﹤0.01% | 6888 |
|
|
2019
Q2 | $657K | Sell |
70,600
-54,000
| -43% | -$625K | ﹤0.01% | 6664 |
|
|
2019
Q1 | $1.73M | Buy |
124,600
+26,500
| +27% | +$303K | ﹤0.01% | 3982 |
|
|
2018
Q4 | $1.07M | Sell |
98,100
-3,000
| -3% | -$31.6K | ﹤0.01% | 4544 |
|
|
2018
Q3 | $1.28M | Buy |
101,100
+83,100
| +462% | +$1M | ﹤0.01% | 4776 |
|
|
2018
Q2 | $237K | Buy |
18,000
+5,400
| +43% | +$64.6K | ﹤0.01% | 8298 |
|
|
2018
Q1 | $171K | Buy |
+12,600
| New | +$130K | ﹤0.01% | 8445 |
|
|
2017
Q1 | – | Sell |
-11,700
| Closed | -$87K | – | 10290 |
|
|
2016
Q4 | $87K | Sell |
11,700
-6,000
| -34% | -$43.2K | ﹤0.01% | 9138 |
|
|
2016
Q3 | $107K | Sell |
17,700
-1,900
| -10% | -$8.98K | ﹤0.01% | 7910 |
|
|
2016
Q2 | $88K | Buy |
+19,600
| New | +$73.5K | ﹤0.01% | 8077 |
|
|
2016
Q1 | – | Sell |
-28,100
| Closed | -$228K | – | 9878 |
|
|
2015
Q4 | $228K | Buy |
28,100
+13,500
| +92% | +$95.5K | ﹤0.01% | 8212 |
|
|
2015
Q3 | $88K | Sell |
14,600
-32,400
| -69% | -$234K | ﹤0.01% | 9193 |
|
|
2015
Q2 | $387K | Buy |
47,000
+12,700
| +37% | +$101K | ﹤0.01% | 8095 |
|
|
2015
Q1 | $259K | Buy |
34,300
+16,900
| +97% | +$132K | ﹤0.01% | 8236 |
|
|
2014
Q4 | $119K | Buy |
+17,400
| New | +$92K | ﹤0.01% | 9129 |
|
|
2014
Q3 | – | Sell |
-54,900
| Closed | -$321K | – | 10100 |
|
|
2014
Q2 | $321K | Buy |
54,900
+27,400
| +100% | +$154K | ﹤0.01% | 8263 |
|
|
2014
Q1 | $182K | Buy |
+27,500
| New | +$191K | ﹤0.01% | 8302 |
|
|
2013
Q4 | – | Sell |
-65,600
| Closed | -$365K | – | 9463 |
|
|
2013
Q3 | $365K | Buy |
+65,600
| New | +$709K | ﹤0.01% | 6917 |
|
Other funds holding CCXI
Susquehanna International Group's CCXI Position: Q4 2022 in Review
Susquehanna International Group sold out of ChemoCentryx, Inc. (CCXI) in Q4 2022, closing a stake of 62,963 shares — an estimated $3.25M sold.
Susquehanna International Group first reported a position in CCXI in Q4 2013 and held it in 24 quarters. The position peaked at $13.5M in Q2 2020. 1 fund tracked by Wall St. Rank holds CCXI as of Q4 2022.
- Susquehanna International Group reported no remaining ChemoCentryx, Inc. position as of Q4 2022 after selling out during the quarter.
- Susquehanna International Group sold 62,963 ChemoCentryx, Inc. shares in Q4 2022, an estimated $3.25M.
- Susquehanna International Group first reported a position in ChemoCentryx, Inc. in Q4 2013 and held it in 24 quarters.
- Susquehanna International Group's ChemoCentryx, Inc. position peaked at $13.5M in Q2 2020.
- 1 fund tracked by Wall St. Rank held ChemoCentryx, Inc. as of Q4 2022.
Based on Susquehanna International Group's 13F filing for Q4 2022, filed 14 Feb 2023.